Back to results
US 8,802,129 B2Granted
Methods for treating retinopathy with extended therapeutic effect
AssigneeAllergan, Inc.
InventorsScott M. Whitcup, David A. Weber
Life of this patent
Estimating the term…
Abstract
Methods for treating and preventing retinopathic conditions by administering a glucocorticoid to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy.
Claims4
A method for treating an ocular condition, the method comprising the steps of:
- a) inserting an implant into an ocular site of a patient with an ocular condition, the implant comprising an active agent and a carrier associated with the active agent;
- b) releasing substantially all of the active agent from the implant;
- c) obtaining an improvement in the ocular condition at a time when a therapeutic amount of the active agent is not present at the ocular site;
- and
- d) maintaining the improvement in the ocular condition for an extended period of time during which the therapeutic amount of the active agent is not present at the ocular site;
- wherein the carrier comprises a 30/10 w/w mixture of hydrophilic end PLGA and hydrophobic end PLGA, wherein the active agent is ranibizumab, wherein the implant is formed by an extrusion method, and wherein the ocular condition is macular degeneration.
3 more elements
Dependencies are inferred from the claim text.